Skip to content

Clinical trials

Observational Adenocarcinoma trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Adenocarcinoma Phase: Observational Country / region: China Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20121
20161
20191
20201
20221
20231
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status4
Completed2
Active, not recruiting1
Not yet recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Berry Genomics Co., Ltd.1
Creative Biosciences (Guangzhou) Co., Ltd.1
Daiichi Sankyo Co., Ltd.1
Fudan University1
Peking University1
Shanghai Zhongshan Hospital1
The First Affiliated Hospital with Nanjing Medical University1
Yonghong Li1
Zhengzhou University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Adenocarcinoma9
Prostatic Neoplasms4
Carcinoma2
Carcinoma, Non-Small-Cell Lung2
Stomach Neoplasms2
Bronchitis1
Bronchitis, Chronic1
Carcinoma, Adenosquamous1
Carcinoma, Large Cell1
Carcinoma, Squamous Cell1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.